Cellular resistance to anthracyclines

Dorte Nielsen(Herlev Hospital), Torben Skovsgaard(Unknown), Christian Maare(Herlev Hospital)

General Pharmacology The Vascular System

March 1, 1996

10.1016/0306-3623(95)02013-6

Cited by 167

Related Papers

Effect of Obesity on Prognosis After Early-Stage Breast Cancer

|Journal of Clinical Oncology|2010|600

Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?

|Cancer Epidemiology Biomarkers & Prevention|2006|364

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

|Cancer Treatment Reviews|2013|328

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

|Journal of Clinical Oncology|1998|285

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

|BMC Pharmacology and Toxicology|2014|264